W.W. Grainger, Inc. 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended June 30, 2007. W.W. Grainger, Inc. is a leading broad-line supplier of facilities maintenance products and services in North America, operating through three segments: Grainger Branch-based, Acklands-Grainger Branch-based (Canada), and Lab Safety Supply, Inc. The company utilizes a multichannel business model including branches, sales representatives, and electronic channels.
Key Financial Metrics
| Metric (in thousands) | Q2 2007 | Q2 2006 | YTD 2007 | YTD 2006 |
|---|---|---|---|---|
| Net Sales | $1,601,011 | $1,482,880 | $3,147,669 | $2,901,997 |
| Gross Profit | $640,465 | $583,305 | $1,272,553 | $1,153,632 |
| Gross Margin | 40.0% | 39.3% | 40.4% | 39.8% |
| Operating Earnings | $166,575 | $144,544 | $329,160 | $278,961 |
| Net Earnings | $104,791 | $93,739 | $206,578 | $179,972 |
| Diluted EPS | $1.21 | $1.02 | $2.38 | $1.95 |
| Cash from Operations (YTD) | $180,334 | $100,523 | ||
| Free Cash Flow (YTD) | ||||
| Total Debt (Short + Long Term) | $15,707 (as of June 30, 2007) | |||
| Cash & Equivalents | $389,390 (as of June 30, 2007) |
Note: Free Cash Flow calculated as Operating Cash Flow less Capital Expenditures ($73,141 + $2,567 = $75,708) for YTD 2007.
Material Changes vs. Prior Period
- Sales Growth: Net sales increased 8.0% in Q2 and 8.5% YTD compared to 2006. Growth was driven by market expansion and product line expansion initiatives, partially offset by the wind-down of low-margin integrated supply contracts.
- Margin Expansion: Gross profit margin improved to 40.0% in Q2 (from 39.3%) and 40.4% YTD (from 39.8%), driven by positive product mix, inflation recovery, and improved freight costs.
- Earnings Growth: Operating earnings rose 15.2% in Q2 and 18.0% YTD. Net earnings increased 11.8% in Q2 and 14.8% YTD.
- One-Time Items: Q2 2006 included a $2.29 million gain on the sale of an unconsolidated entity (USI-AGI Prairies joint venture), which was not present in Q2 2007, contributing to a decrease in "Other income."
- Segment Performance:
- Grainger Branch-based: Sales up 8.0% (Q2) and 9.1% (YTD). Mexico sales grew significantly (26.1% Q2).
- Acklands-Grainger: Sales up 8.4% (Q2); Operating earnings surged 243% due to margin improvement and lower payroll/severance costs.
- Lab Safety: Sales up 6.9% (Q2), aided by acquisitions. Gross margin decreased slightly due to mix.
Guidance, Outlook, and Risks
- Strategic Initiatives: The company expects to continue investments in its market expansion program through 2008. Capital expenditures for the first six months of 2007 were $81.7 million, with $33.8 million allocated to market expansion.
- Acquisitions: On May 31, 2007, the company acquired McFeely's Square Drive Screws for approximately $4.8 million in cash. Results are included from the date of acquisition.
- Dividends: A quarterly dividend of $0.35 per share was declared on July 25, 2007, payable September 1, 2007.
- Share Repurchases: The company repurchased 1.7 million shares in the first six months of 2007. Approximately 6.0 million shares remained available under the repurchase authorization as of June 30, 2007.
- Risks: Forward-looking statements are subject to risks including higher product costs, competitive pricing pressure, failure to implement new technologies, litigation outcomes, and general economic conditions affecting industrial production and employment.
Investor Verification Checklist
- Margin Sustainability: Verify if the gross margin improvement (driven by inflation recovery and mix) is sustainable given potential cost increases.
- Market Expansion ROI: Assess the return on the $33.8 million invested in market expansion and the completion status of Phase 5 (55% complete).
- Integrated Supply Contracts: Monitor the impact of the wind-down of low-margin integrated supply contracts on future sales growth rates.
- Debt and Liquidity: Confirm the stability of the debt-to-capitalization ratio (0.7%) and the utilization of the $21.0 million credit line in China.
- Acquisition Integration: Review the performance of the McFeely's acquisition and other Lab Safety acquisitions in subsequent quarters.